🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Final program for the CTD ILD included here. Happy New Year! 🎇🎇 Register below. World Scleroderma Foundation internationalild2025.virtualevent.it

I am honored to be invited to Boston University to deliver the Korn Memorial Medicine Grand Rounds U-M Department of Internal Medicine

With interest in cellular therapies in autoimmune diseases, our recent publication discusses outcomes and risks of non-myeloablative stem cell transplant in scleroderma. low pretransplant eGFR is a key risk factor for poor outcomes. ACR_Journals pubmed.ncbi.nlm.nih.gov/39624016/

膠原病に伴う間質性肺疾患に関する国際シンポジウムも今回で5回目です。明日からの開催です。視聴は無料でオンライン登録制になります。 1/17 金 日本時間 22:00-26:30 1/18 土 日本時間 22:00-26:30 1/19 日 日本時間 22:00-26:30

Day#2 starting in 30 minutes. A very successful Day#1 with 700 attendees from 55 countries! Below is link to the symposium on ILDs in CTDs. internationalild2025.virtualevent.it World Scleroderma Foundation -Sjogren and ANCA associated ILD/ lung dz -Case based discussion from Vivek Nagaraja and colleagues

Upcoming lectures by Toby Maher Vincent Cottin New therapies on the Horizon in ILDs.

ILD in India and management of ILD in prevalent TB by Sujeet Rajan 1. IPF 14%, CTDILD 14%, HP 43%! 2.40% of Indian subpopulation has latent TB! 3. NPV for Quantiferon TB/TST is 96% for developing TB 4. Latent TB treatment with INH and RIF for 3 months or INH for 6 month with bio

NEW RESEARCH—In a phase 2 trial, faecal #microbiota transplantation was well tolerated in participants with systemic sclerosis and lower #gastrointestinal tract symptoms, but did not result in an improvement in symptoms thelancet.com/journals/lanrh…

Congratulations to EUSTAR for putting an excellent course in Bordeaux, France. World Scleroderma Foundation Professor Francesco Del Galdo SRFCure Great to see the dedication of the EUSTAR for training the next group of scleroderma researchers!

Pulmonary Rehabilitation has short-term benefits in CTD-ILD. See our latest article. A prospective study affected by the pandemic. Took 5-years and three journals to publish. journals.sagepub.com/doi/10.1177/09… Thanks to Dr. Dinesh Khanna, Rosemary Gedert, and team

NEW RESEARCH—Serum type I #interferon score as a disease activity biomarker in patients with diffuse cutaneous #SystemicSclerosis: a retrospective cohort study bit.ly/3Eh7Q5r

Advances and future outlook in clinical trials for treating systemic sclerosis-interstitial lung disease tandfonline.com/doi/full/10.10… Free copy available for download